Notably, similar risks for contracting COVID-19 or having a more severe course of disease have been observed in patients treated with biologics or topical therapies (48), possibly resulting from furin normalization in patients treated with biologics or topical therapy. This evidence concerns the gene FURIN and COVID-19.